Activatingmutations in the KRAS gene can lead to continuous activation of thecell surface receptor EGFR, resulting in uncontrolled cell growth.178 Detection and monitoring of these mutationsare of great significance in the field of cancer, as they are associatedwith poor prognosis and resistance to targeted therapies. The gene discussed is EGFR; the disease is cancer.